Abstract
In summary, our study highlights the importance of TBX3 as a cooperating partner of E6/E7 in HPV-positive cervical cancer and identifies TBX3 as a potential therapeutic target to treat this neoplasm.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have